RESOLVE: Improving health status and symptom experience of Yorkshire cancer patients
In Yorkshire, over 14,000 people die from advanced cancer each year, a number expected to rise to 17,000 yearly by 2030.
In the weeks or months before they die, people with advanced cancer often experience pain, breathlessness or fatigue-exhaustion, which significantly reduce quality of remaining life.
Funded by Yorkshire Cancer Research, our RESOLVE: Resolving Symptoms in Cancer programme will directly improve the health status and symptom experience of Yorkshire patients living with advanced cancer and support their families.
We worked with 11 palliative care service providers across Yorkshire to understand the best ways to implement Person-Centred Outcome Measures into clinical practice, in order to improve the quality of palliative care that is provided to patients and their families.
We engaged with healthcare professionals of varied roles and experience in organising and conducting regional workshop conferences, training days, and tailored support that responds to the most common challenges that they have experienced when implementing outcome measures. These events have been well-received and have acted as a valuable platform that has facilitated shared learning between participating sites and the research team.
An integral part of this work is building a Yorkshire-wide Palliative Care Outcomes Registry which will drive quality improvement in participating sites by using aggregated outcomes data to provide them with service-level feedback on areas of their service working well to address patient symptoms and concerns, and areas for improvement.
To ensure that this Registry is feasible, acceptable, and includes information that reflects the things that matter most to patients, we engaged with a Palliative Day-care Patient Group at Marie Curie Bradford Hospice. Patients appreciated the opportunity to inform the development and design of the Registry and offered constructive feedback which we have since used in further refining our protocol and patient-facing material.